6826612
Last Update Posted: 2025-05-22
Recruiting
All Genders accepted | 25 Years-65 Years |
53 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
The main goal of this study is to evaluate the safety, tolerability, and preliminary efficacy of SPK-10001 in participants with Huntington's Disease.
Eligibility
Relevant conditions:
Huntington Disease
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov